Indian drug firm Wockhardt announces exit from its loss-incurring US generic business to concentrate on innovative ...

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...

This multi-state settlement addresses makers of generic versions of opioids and is up to $720 million, officials said.

Wockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing ...

Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

Wockhardt Ltd on July 11 said it has decided to exit US generic pharmaceutical segment to unlock capital for high-impact ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

Far from the triumphant return to form DC and Warner Bros hoped for, James Gunn's 'Superman' is a generic, dull, overwritten ...

The 21217 ZIP code, which encompasses the Penn North neighborhood where Thursday’s overdoses took place, was by far the ...

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...